CD19 and neoplasm: To demonstrate the functionality of the short-term generated CAR T cells, Nalm6 cells (luciferase-encoding CD19-positive target cells) were intravenously injected into the mice 3 days later, and tumor growth was monitored by bioluminescence imaging (BLI).